Feasibility, effectiveness, and experiences of music workshops for adolescents with anxiety and depressio

Not Applicable

Completed

• Conditions: Adolescents with symptoms of depression and anxiety; Mental and Behavioural Disorders

• Registration Number: ISRCTN50583823
• Lead Sponsor: Queen Mary University of London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-21
• Study Completion: 2022-06-24
• Last Update Posted: 27 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

All participants:
1. Enrolled in the OLA longitudinal cohort study
2. Aged 15-16 years when recruited to the OLA study
3. Symptoms of anxiety and/or depression at baseline and 6-month follow-up during the OLA study

Intervention group only:
1. Capacity to provide assent
2. Informed consent provided by a parent/guardian

Exclusion Criteria

1. Already regularly participate in a music band/orchestra, or have advanced music skills as determined during baseline assessment
2. Expressed no interest in participating in any arts activities during baseline assessment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 14/02/2024:<br>Effectiveness measured using self-rated depression/anxiety symptoms by the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at the beginning (baseline) and five (5) weeks<br><br><br>Previous primary outcome measure as of 06/05/2022 to 14/02/2024:<br>Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at 12-months follow-up, adjusted for the 6-months follow-up scores, of intervention and control group, supplemented with pre-post intervention changes (baseline and 5 weeks) of self-rated depression/anxiety symptoms as measured by PHQ-8 and GAD-7<br><br><br>Previous primary outcome measure:<br>Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at baseline and 5 weeks

Secondary Outcome Measures

Name	Time	Method
1. Feasibility measured using the acceptance of workshop participation and attendance of workshop sessions at 5 weeks<br>2. Experiences measured using open-ended exit questions at 5 weeks